Log In
Print this Print this

Taxus Liberte Long Paclitaxel-Eluting Coronary Stent System

  Manage Alerts
Collapse Summary General Information
Company Boston Scientific Corp.
DescriptionNext-generation paclitaxel-eluting stent for long lesions
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation
PartnerAngiotech Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today